Najat Khan, PhD: From Pharma to TechBio

Few people understand the TechBio transformation of pharma like Najat Khan, PhD.
Here, 90 days into her new role as Chief R&D and Chief Commercial Officer at Recursion, having previously led the data science and AI team at J&J, she sat down to talk about what motivates her, why she made the leap from pharma to TechBio, and why AI drug discovery and development is ready to deliver.
#ai #techbio #pharma #drugdiscovery #career #data #compute #technology #future